Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR » 09:59
07/02/20
07/02
09:59
07/02/20
09:59
NVAX

Novavax

$79.15 /

-0.55 (-0.69%)

, PFE

Pfizer

$34.29 /

+0.55 (+1.63%)

, BNTX

BioNTech

$68.28 /

+4.19 (+6.54%)

B. Riley FBR analyst…

B. Riley FBR analyst Mayank Mamtani tells investors to take advantage of the pullback in Novavax (NVAX) shares after Pfizer (PFE) and BioNTech (BNTX) released preliminary Phase I/II safety and immunogenicity dataset for its mRNA-based COVID-19 vaccine candidate. The analyst is encouraged by the "first-of-its-kind detailed update" for a clinical stage COVID-19 vaccine and does not believe the data confer negative read-through to alternative platform approaches. Safety and dose-dependent effect could emerge as key differentiating factors for Novavax, Mamtani tells investors in a research note. The analyst keeps a Buy rating on Novavax with a $106 price target.

ShowHide Related Items >><<
PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
06/29/20 H.C. Wainwright
Novavax price target raised to $101 from $50 at H.C. Wainwright
06/19/20 Cantor Fitzgerald
Novavax price target raised to $88 from $45 at Cantor Fitzgerald
06/05/20
Fly Intel: Top five analyst upgrades
PFE Pfizer
$34.29 /

+0.55 (+1.63%)

07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
07/02/20 SVB Leerink
BioNTech price target raised to $42 from $37 at SVB Leerink
07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
BNTX BioNTech
$68.28 /

+4.19 (+6.54%)

07/02/20 Bryan Garnier
BioNTech price target raised to $62.50 from $50 at Bryan Garnier
PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

BNTX BioNTech
$68.28 /

+4.19 (+6.54%)

  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

BNTX BioNTech
$68.28 /

+4.19 (+6.54%)

PFE Pfizer
$34.29 /

+0.55 (+1.63%)

NVAX Novavax
$79.15 /

-0.55 (-0.69%)

BNTX BioNTech
$68.28 /

+4.19 (+6.54%)

Recommendations
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital » 09:18
07/02/20
07/02
09:18
07/02/20
09:18
MRNA

Moderna

$61.63 /

-2.6 (-4.05%)

, PFE

Pfizer

$33.74 /

+1.05 (+3.21%)

, BNTX

BioNTech

$64.14 /

-2.595 (-3.89%)

BMO Capital analyst…

BMO Capital analyst George Farmer keeps his Outperform rating and $112 price target on Moderna (MRNA), saying the positive results from the Phase 1/2 trial evaluating mRNA/LNP-based coronavirus vaccine from Pfizer (PFE) and BioNTech (BNTX) support the utility of this technology. While the study sets up a "competitive race" between the two vaccine trials, the analyst contends that the potential market is "certainly large enough" to accommodate both. Pending the "imminent" publication of Moderna's NIAID's Phase 1 results, Farmer is keeping his model assumptions intact.

ShowHide Related Items >><<
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

MRNA Moderna
$61.63 /

-2.6 (-4.05%)

MRNA Moderna
$61.63 /

-2.6 (-4.05%)

06/30/20 Argus
Moderna initiated with a Buy at Argus
06/30/20 Argus
Moderna initiated with a Buy at Argus
06/26/20 Morgan Stanley
Morgan Stanley says Axios overstates contention on Moderna-NIH vaccine ownership
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

07/02/20 SVB Leerink
BioNTech price target raised to $42 from $37 at SVB Leerink
07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

07/02/20 Bryan Garnier
BioNTech price target raised to $62.50 from $50 at Bryan Garnier
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

MRNA Moderna
$61.63 /

-2.6 (-4.05%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

  • 19
    May
  • 12
    Feb
  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

MRNA Moderna
$61.63 /

-2.6 (-4.05%)

PFE Pfizer
$33.74 /

+1.05 (+3.21%)

MRNA Moderna
$61.63 /

-2.6 (-4.05%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

PFE Pfizer
$33.74 /

+1.05 (+3.21%)

MRNA Moderna
$61.63 /

-2.6 (-4.05%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

Recommendations
BioNTech price target raised to $42 from $37 at SVB Leerink » 08:09
07/02/20
07/02
08:09
07/02/20
08:09
BNTX

BioNTech

$64.14 /

-2.595 (-3.89%)

, PFE

Pfizer

$33.74 /

+1.05 (+3.21%)

SVB Leerink analyst Daina…

SVB Leerink analyst Daina Graybosch raised the firm's price target on BioNTech (BNTX) to $42 from $37 and keeps a Market Perform rating on the shares. The analyst notes that the increase reflects an assumed increase in probability of technical and regulatory success after the company and partner Pfizer (PFE) reported immunogenicity data for 36 subjects vaccinated with BNT-162b1, a modRNA vaccine against the receptor-binding domain of the SARS-CoV-2 spike protein. Further, Graybosch also expects additional immunogenicity data in the coming weeks to be positive, which, likely, will result in more upside for BioNTech's stock.

ShowHide Related Items >><<
BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

07/02/20 Bryan Garnier
BioNTech price target raised to $62.50 from $50 at Bryan Garnier
07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$33.74 /

+1.05 (+3.21%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

PFE Pfizer
$33.74 /

+1.05 (+3.21%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

PFE Pfizer
$33.74 /

+1.05 (+3.21%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

Recommendations
BioNTech price target raised to $62.50 from $50 at Bryan Garnier » 05:14
07/02/20
07/02
05:14
07/02/20
05:14
BNTX

BioNTech

$64.14 /

-2.595 (-3.89%)

Bryan Garnier analyst…

Bryan Garnier analyst Olga Smolentseva raised the firm's price target on BioNTech to $62.50 from $50 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

  • 06
    Feb
  • 10
    Oct
BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

Wednesday
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:27
07/01/20
07/01
16:27
07/01/20
16:27
PFE

Pfizer

$33.75 /

+1.06 (+3.24%)

, BNTX

BioNTech

$64.14 /

-2.595 (-3.89%)

, FDX

FedEx

$156.86 /

+16.61 (+11.84%)

, STZ

Constellation Brands

$185.85 /

+11.415 (+6.54%)

, GM

General Motors

$24.95 /

-0.35 (-1.38%)

, FCAU

Fiat Chrysler

$9.90 /

-0.345 (-3.37%)

, VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

, HMC

Honda

$25.37 /

-0.19 (-0.74%)

, AAPL

Apple

$364.11 /

-0.35 (-0.10%)

, AKRO

Akero Therapeutics

$33.50 /

+8.65 (+34.81%)

, AXGN

AxoGen

$11.74 /

+2.48 (+26.78%)

, INO

Inovio

$19.73 /

-7.15 (-26.60%)

, SCS

Steelcase

$10.38 /

-1.69 (-14.00%)

The S&P began the third…

Open Full Text

ShowHide Related Items >><<
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

SCS Steelcase
$10.38 /

-1.69 (-14.00%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

INO Inovio
$19.73 /

-7.15 (-26.60%)

HMC Honda
$25.37 /

-0.19 (-0.74%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

AXGN AxoGen
$11.74 /

+2.48 (+26.78%)

AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

07/02/20 Bryan Garnier
BioNTech price target raised to $62.50 from $50 at Bryan Garnier
06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
FDX FedEx
$156.86 /

+16.61 (+11.84%)

07/01/20
Fly Intel: Top five analyst upgrades
07/01/20 Cowen
FedEx price target raised to $167 from $156 at Cowen
07/01/20 Wells Fargo
FedEx price target raised to $179 from $153 at Wells Fargo
07/01/20 Baird
FedEx price target raised to $162 from $140 at Baird
STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

07/02/20 UBS
Constellation Brands price target raised to $208 from $192 at UBS
07/02/20 Jefferies
Constellation Brands price target raised to $238 from $224 at Jefferies
07/02/20 Citi
Constellation Brands price target raised to $200 from $176 at Citi
07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
GM General Motors
$24.95 /

-0.35 (-1.38%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
General Motors price target raised to $33 from $29 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

06/30/20 UBS
Fiat Chrysler price target raised to EUR 9 from EUR 6 at UBS
06/22/20 Redburn
Fiat Chrysler upgraded to Buy from Neutral at Redburn
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

06/30/20 UBS
Volkswagen price target raised to EUR 180 from EUR 140 at UBS
06/18/20 Jefferies
Volkswagen price target raised to EUR 135 from EUR 115 at Jefferies
06/16/20 BofA
Volkswagen downgraded to Neutral from Buy at BofA
HMC Honda
$25.37 /

-0.19 (-0.74%)

05/12/20 CLSA
Honda downgraded to Underperform from Outperform at CLSA
04/13/20 Goldman Sachs
Honda upgraded to Buy from Neutral at Goldman Sachs
03/30/20 UBS
Toyota and Honda upgraded to Buy, Nissan cut to Sell at UBS
AAPL Apple
$364.11 /

-0.35 (-0.10%)

06/26/20 Evercore ISI
Evercore upgrades Broadcom to Outperform, sees Apple sales driving upside
06/25/20 Wedbush
Wedbush boosts Apple target to $425, sees $2 trillion valuation in 2021
06/24/20 BMO Capital
Criteo downgraded to Market Perform from Outperform at BMO Capital
06/23/20 Baird
Apple price target raised to $390 from $320 at Baird
AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

07/01/20 JPMorgan
Akero Therapeutics price target raised to $41 from $28 at JPMorgan
07/01/20 Jefferies
Akero Therapeutics price target raised to $48 from $31 at Jefferies
07/01/20 Canaccord
Akero Therapeutics price target raised to $51 from $36 at Canaccord
07/01/20 H.C. Wainwright
Akero Therapeutics price target raised to $45 from $33 at H.C. Wainwright
AXGN AxoGen
$11.74 /

+2.48 (+26.78%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
INO Inovio
$19.73 /

-7.15 (-26.60%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
07/01/20 Roth Capital
Roth 'unimpressed' with Inovio data, downgrades to Sell with $11 target
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
SCS Steelcase
$10.38 /

-1.69 (-14.00%)

05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
10/07/19 Raymond James
Raymond James steps away from three office furniture stocks
10/07/19 Raymond James
Steelcase downgraded to Market Perform from Strong Buy at Raymond James
09/23/19 Raymond James
Steelcase price target raised to $23 from $21 at Raymond James
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

SCS Steelcase
$10.38 /

-1.69 (-14.00%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

INO Inovio
$19.73 /

-7.15 (-26.60%)

HMC Honda
$25.37 /

-0.19 (-0.74%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

AXGN AxoGen
$11.74 /

+2.48 (+26.78%)

AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

  • 06
    Feb
  • 10
    Oct
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

INO Inovio
$19.73 /

-7.15 (-26.60%)

HMC Honda
$25.37 /

-0.19 (-0.74%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

STZ Constellation Brands
$185.85 /

+11.415 (+6.54%)

SCS Steelcase
$10.38 /

-1.69 (-14.00%)

PFE Pfizer
$33.75 /

+1.06 (+3.24%)

INO Inovio
$19.73 /

-7.15 (-26.60%)

GM General Motors
$24.95 /

-0.35 (-1.38%)

FDX FedEx
$156.86 /

+16.61 (+11.84%)

FCAU Fiat Chrysler
$9.90 /

-0.345 (-3.37%)

BNTX BioNTech
$64.14 /

-2.595 (-3.89%)

AKRO Akero Therapeutics
$33.50 /

+8.65 (+34.81%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

AAPL Apple
$364.11 /

-0.35 (-0.10%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:07
07/01/20
07/01
12:07
07/01/20
12:07
PFE

Pfizer

$34.14 /

+1.45 (+4.44%)

, BNTX

BioNTech

$70.80 /

+4.065 (+6.09%)

, FDX

FedEx

$159.00 /

+18.75 (+13.37%)

, STZ

Constellation Brands

$187.97 /

+13.54 (+7.76%)

, GM

General Motors

$25.13 /

-0.17 (-0.67%)

, FCAU

Fiat Chrysler

$9.86 /

-0.38 (-3.71%)

, AKRO

Akero Therapeutics

$32.03 /

+7.18 (+28.89%)

, AXGN

AxoGen

$11.60 /

+2.34 (+25.27%)

, INO

Inovio

$21.08 /

-5.8 (-21.58%)

, SCS

Steelcase

$10.67 /

-1.4 (-11.60%)

The major averages are…

Open Full Text

ShowHide Related Items >><<
STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

SCS Steelcase
$10.67 /

-1.4 (-11.60%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

AXGN AxoGen
$11.60 /

+2.34 (+25.27%)

AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
BNTX BioNTech
$70.80 /

+4.065 (+6.09%)

06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
FDX FedEx
$159.00 /

+18.75 (+13.37%)

07/01/20
Fly Intel: Top five analyst upgrades
07/01/20 Cowen
FedEx price target raised to $167 from $156 at Cowen
07/01/20 Wells Fargo
FedEx price target raised to $179 from $153 at Wells Fargo
07/01/20 Baird
FedEx price target raised to $162 from $140 at Baird
STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/17/20 JPMorgan
Constellation Brands added to Analyst Focus List at JPMorgan
06/01/20 Cowen
Constellation Brands price target raised to $205 from $160 at Cowen
05/20/20 MKM Partners
MKM Partners sees negative pre-announcement as likely from Constellation Brands
GM General Motors
$25.13 /

-0.17 (-0.67%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
General Motors price target raised to $33 from $29 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

06/30/20 UBS
Fiat Chrysler price target raised to EUR 9 from EUR 6 at UBS
06/22/20 Redburn
Fiat Chrysler upgraded to Buy from Neutral at Redburn
AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

07/01/20 JPMorgan
Akero Therapeutics price target raised to $41 from $28 at JPMorgan
07/01/20 Jefferies
Akero Therapeutics price target raised to $48 from $31 at Jefferies
07/01/20 Canaccord
Akero Therapeutics price target raised to $51 from $36 at Canaccord
07/01/20 H.C. Wainwright
Akero Therapeutics price target raised to $45 from $33 at H.C. Wainwright
AXGN AxoGen
$11.60 /

+2.34 (+25.27%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
INO Inovio
$21.08 /

-5.8 (-21.58%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
07/01/20 Roth Capital
Roth 'unimpressed' with Inovio data, downgrades to Sell with $11 target
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
SCS Steelcase
$10.67 /

-1.4 (-11.60%)

05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
10/07/19 Raymond James
Raymond James steps away from three office furniture stocks
10/07/19 Raymond James
Steelcase downgraded to Market Perform from Strong Buy at Raymond James
09/23/19 Raymond James
Steelcase price target raised to $23 from $21 at Raymond James
STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

SCS Steelcase
$10.67 /

-1.4 (-11.60%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

BNTX BioNTech
$70.80 /

+4.065 (+6.09%)

AXGN AxoGen
$11.60 /

+2.34 (+25.27%)

AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

  • 06
    Feb
  • 10
    Oct
STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

SCS Steelcase
$10.67 /

-1.4 (-11.60%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

BNTX BioNTech
$70.80 /

+4.065 (+6.09%)

AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

STZ Constellation Brands
$187.97 /

+13.54 (+7.76%)

SCS Steelcase
$10.67 /

-1.4 (-11.60%)

PFE Pfizer
$34.14 /

+1.45 (+4.44%)

INO Inovio
$21.08 /

-5.8 (-21.58%)

GM General Motors
$25.13 /

-0.17 (-0.67%)

FDX FedEx
$159.00 /

+18.75 (+13.37%)

FCAU Fiat Chrysler
$9.86 /

-0.38 (-3.71%)

BNTX BioNTech
$70.80 /

+4.065 (+6.09%)

AKRO Akero Therapeutics
$32.03 /

+7.18 (+28.89%)

On The Fly
Analyst says sell Inovio on 'unimpressive' COVID vaccine data » 11:33
07/01/20
07/01
11:33
07/01/20
11:33
INO

Inovio

$22.29 /

-4.59 (-17.08%)

, PFE

Pfizer

$34.30 /

+1.61 (+4.93%)

, BNTX

BioNTech

$69.96 /

+3.225 (+4.83%)

Shares of Inovio…

Open Full Text

ShowHide Related Items >><<
PFE Pfizer
$34.30 /

+1.61 (+4.93%)

INO Inovio
$22.29 /

-4.59 (-17.08%)

INO Inovio
$22.29 /

-4.59 (-17.08%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
07/01/20 Roth Capital
Roth 'unimpressed' with Inovio data, downgrades to Sell with $11 target
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
PFE Pfizer
$34.30 /

+1.61 (+4.93%)

07/01/20 Goldman Sachs
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs
06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
BNTX BioNTech
$69.96 /

+3.225 (+4.83%)

07/02/20 Bryan Garnier
BioNTech price target raised to $62.50 from $50 at Bryan Garnier
06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
PFE Pfizer
$34.30 /

+1.61 (+4.93%)

INO Inovio
$22.29 /

-4.59 (-17.08%)

BNTX BioNTech
$69.96 /

+3.225 (+4.83%)

  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$34.30 /

+1.61 (+4.93%)

INO Inovio
$22.29 /

-4.59 (-17.08%)

PFE Pfizer
$34.30 /

+1.61 (+4.93%)

INO Inovio
$22.29 /

-4.59 (-17.08%)

BNTX BioNTech
$69.96 /

+3.225 (+4.83%)

PFE Pfizer
$34.30 /

+1.61 (+4.93%)

INO Inovio
$22.29 /

-4.59 (-17.08%)

BNTX BioNTech
$69.96 /

+3.225 (+4.83%)

Recommendations
Pfizer COVID-19 vaccine data 'encouraging,' says Goldman Sachs » 10:47
07/01/20
07/01
10:47
07/01/20
10:47
PFE

Pfizer

$34.17 /

+1.48 (+4.53%)

, BNTX

BioNTech

$70.72 /

+3.985 (+5.97%)

Goldman Sachs analyst…

Goldman Sachs analyst Terence Flynn, who does not have a rating on Pfizer (PFE), said the initial Phase 1 data from the first of four COVID-19 vaccine candidates that the company developing with partner BioNTech (BNTX) was "encouraging," noting that the candidate showed the ability to generate an immune response higher than that from a panel of plasma from recovered patients along with an "acceptable" safety and tolerability profile. Flynn expects additional data from three other candidates over the coming weeks, which should allow for the selection of a lead candidate and a larger Phase 2b/3 trial that could start as soon as this month.

ShowHide Related Items >><<
PFE Pfizer
$34.17 /

+1.48 (+4.53%)

PFE Pfizer
$34.17 /

+1.48 (+4.53%)

06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
BNTX BioNTech
$70.72 /

+3.985 (+5.97%)

06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
04/28/20 BofA
BioNTech downgraded to Neutral from Buy at BofA
PFE Pfizer
$34.17 /

+1.48 (+4.53%)

BNTX BioNTech
$70.72 /

+3.985 (+5.97%)

  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$34.17 /

+1.48 (+4.53%)

PFE Pfizer
$34.17 /

+1.48 (+4.53%)

BNTX BioNTech
$70.72 /

+3.985 (+5.97%)

PFE Pfizer
$34.17 /

+1.48 (+4.53%)

BNTX BioNTech
$70.72 /

+3.985 (+5.97%)

On The Fly
Fly Intel: Pre-market Movers » 09:07
07/01/20
07/01
09:07
07/01/20
09:07
PFE

Pfizer

$32.69 /

+0.04 (+0.12%)

, BNTX

BioNTech

$66.74 /

+1.025 (+1.56%)

, YRCW

YRC Worldwide

$1.84 /

+0.095 (+5.44%)

, TTOO

T2 Biosystems

$1.27 /

-0.03 (-2.31%)

, MYOS

MYOS

$0.88 /

-0.0052 (-0.58%)

, AXGN

AxoGen

$9.26 /

+0.11 (+1.20%)

, STZ

Constellation Brands

$174.43 /

+0.46 (+0.26%)

, FDX

FedEx

$140.25 /

+5.86 (+4.36%)

, GM

General Motors

$25.30 /

+0.01 (+0.04%)

, CNHI

CNH Industrial

$7.03 /

-0.015 (-0.21%)

, IHRT

iHeartMedia

$8.36 /

-0.09 (-1.07%)

, DENN

Denny's

$10.10 /

-0.13 (-1.27%)

, SCS

Steelcase

$12.07 /

-0.135 (-1.11%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
YRCW YRC Worldwide
$1.84 /

+0.095 (+5.44%)

TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

MYOS MYOS
$0.88 /

-0.0052 (-0.58%)

IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CNHI CNH Industrial
$7.03 /

-0.015 (-0.21%)

AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
04/28/20 BofA
BioNTech downgraded to Neutral from Buy at BofA
YRCW YRC Worldwide
$1.84 /

+0.095 (+5.44%)

10/31/19 Seaport Global
YRC Worldwide has defined path forward, says Seaport Global
07/12/19 Loop Capital
Loop Capital cuts FY19 EPS view on YRC Worldwide on unexpected HQ consolidation
TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

02/06/20 JonesTrading
T2 Biosystems upgraded to Buy from Hold at JonesTrading
01/23/20 Alliance Global Partners
T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
11/26/19 Janney Montgomery Scott
T2 Biosystems downgraded to Neutral at Janney Montgomery Scott
11/26/19 Janney Montgomery Scott
T2 Biosystems downgraded to Neutral from Buy at Janney Montgomery Scott
MYOS MYOS
$0.88 /

-0.0052 (-0.58%)

AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
05/07/20 Canaccord
AxoGen downgraded to Hold from Buy at Canaccord
STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/17/20 JPMorgan
Constellation Brands added to Analyst Focus List at JPMorgan
06/01/20 Cowen
Constellation Brands price target raised to $205 from $160 at Cowen
05/20/20 MKM Partners
MKM Partners sees negative pre-announcement as likely from Constellation Brands
FDX FedEx
$140.25 /

+5.86 (+4.36%)

07/01/20 Cowen
FedEx price target raised to $167 from $156 at Cowen
07/01/20 Wells Fargo
FedEx price target raised to $179 from $153 at Wells Fargo
07/01/20 Baird
FedEx price target raised to $162 from $140 at Baird
07/01/20 Raymond James
FedEx price target raised to $165 from $150 at Raymond James
GM General Motors
$25.30 /

+0.01 (+0.04%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
General Motors price target raised to $33 from $29 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
CNHI CNH Industrial
$7.03 /

-0.015 (-0.21%)

07/01/20 Deutsche Bank
CNH Industrial resumed with a Hold at Deutsche Bank
06/22/20 JPMorgan
CNH Industrial price target raised to $8 from $6.50 at JPMorgan
04/20/20 OTR Global
Farm Equipment Manufacturers downgraded to Negative at OTR Global
04/13/20 BofA
CNH Industrial downgraded to Underperform from Neutral at BofA
IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
04/23/20 Guggenheim
iHeartMedia price target lowered to $10 from $21.50 at Guggenheim
04/15/20 Barrington
iHeartMedia price target lowered to $12 from $20 at Barrington
DENN Denny's
$10.10 /

-0.13 (-1.27%)

06/17/20 SunTrust
Denny's price target raised to $15 from $12 at SunTrust
05/15/20 Stephens
Stephens reiterates Overweight rating on Denny's after Q1 report
04/08/20 Oppenheimer
Denny's price target lowered to $13 from $27 at Oppenheimer
04/01/20 SunTrust
El Pollo Loco upgraded to Buy from Hold at SunTrust
SCS Steelcase
$12.07 /

-0.135 (-1.11%)

05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
10/07/19 Raymond James
Raymond James steps away from three office furniture stocks
10/07/19 Raymond James
Steelcase downgraded to Market Perform from Strong Buy at Raymond James
09/23/19 Raymond James
Steelcase price target raised to $23 from $21 at Raymond James
YRCW YRC Worldwide
$1.84 /

+0.095 (+5.44%)

TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CNHI CNH Industrial
$7.03 /

-0.015 (-0.21%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

AXGN AxoGen
$9.26 /

+0.11 (+1.20%)

  • 01
    Jul
  • 06
    Feb
  • 10
    Oct
STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

TTOO T2 Biosystems
$1.27 /

-0.03 (-2.31%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

CNHI CNH Industrial
$7.03 /

-0.015 (-0.21%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

STZ Constellation Brands
$174.43 /

+0.46 (+0.26%)

SCS Steelcase
$12.07 /

-0.135 (-1.11%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

IHRT iHeartMedia
$8.36 /

-0.09 (-1.07%)

GM General Motors
$25.30 /

+0.01 (+0.04%)

FDX FedEx
$140.25 /

+5.86 (+4.36%)

DENN Denny's
$10.10 /

-0.13 (-1.27%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

Hot Stocks
Pfizer, BioNTech announce preliminary data from SARS-CoV-2 vaccine candidates » 09:06
07/01/20
07/01
09:06
07/01/20
09:06
PFE

Pfizer

$32.69 /

+0.04 (+0.12%)

, BNTX

BioNTech

$66.74 /

+1.025 (+1.56%)

Pfizer (PFE) and BioNTech…

Pfizer (PFE) and BioNTech (BNTX) announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program, Project Lightspeed, against SARS-CoV-2, the virus causing the current global pandemic. The BNT162 program is evaluating at least four experimental vaccines, each of which represents a combination of mRNA format and target antigen. Overall, the preliminary data demonstrated that BNT162b1 could be administered in a dose that was well tolerated and generated dose dependent immunogenicity, as measured by RBD-binding IgG concentrations and SARS-CoV-2 neutralizing antibody titers. The ongoing U.S. Phase 1/2 randomized, placebo-controlled, observer-blinded study is evaluating the safety, tolerability, and immunogenicity of escalating dose levels of BNT162b1. The initial part of the study included 45 healthy adults 18 to 55 years of age. Preliminary data for BNT162b1 was evaluated for 24 subjects who received two injections of 10 microgram and 30 microgram, 12 subjects who received a single injection of 100 microgram, and 9 subjects who received 2 doses of placebo control. The participants received two doses, 21 days apart, of placebo, 10 microgram or 30 microgram of BNT162b1, or received a single dose of 100 microgram of the vaccine candidate. Because of a strong vaccine booster effect, the highest neutralizing titers were observed seven days after the second dose of 10 microgram or 30 microgram on day 28 after vaccination. The neutralizing GMTs were 168 and 267 for the 10 microgram and 30 microgram dose levels, respectively, corresponding to 1.8- and 2.8-times the neutralizing GMT of 94 observed in a panel of 38 sera from subjects who had contracted SARS-CoV-2. In all 24 subjects who received two vaccinations at 10 microgram and 30 microgram dose levels of BNT162b1, elevation of RBD-binding IgG concentrations was observed after the second injection with respective GMCs of 4,813 and 27,872 units/ml at day 28, seven days after immunization. These concentrations are 8- and 46.3-times the GMC of 602 units/ml in a panel of 38 sera from subjects who had contracted SARS-CoV-2. At day 21 after a single injection, the 12 subjects who received 100 microgram of BNT162b1 had an RBD-binding IgG GMC of 1,778 units/ml and a SARS-CoV neutralizing GMT of 33, which are 3-times and 0.35-times, respectively, the GMC and GMT of the convalescent serum panel. At the 10 microgram or 30 microgram dose levels, adverse reactions, including low grade fever, were more common after the second dose than the first dose. Following dose two, 8.3% of participants who received 10 microgram and 75% of participants who received 30 microgram BNT162b1 reported fever. Local reactions and systemic events after injection with 10 microgram and 30 microgram of BNT162b1 were dose-dependent, generally mild to moderate, and transient. The most commonly reported local reaction was injection site pain, which was mild to moderate, except in one of 12 subjects who received a 100 microgram dose, which was severe. No serious adverse events were reported. Given higher numbers of subjects experiencing local reactions and systemic events after a single 100 microgram dose with no significant increases in immunogenicity compared to the 30 microgram dose level, the 12 participants in the 100 microgram group were not administered a second dose. These preliminary data, together with additional preclinical and clinical data being generated, will be used by the two companies to determine a dose level and select among multiple vaccine candidates to seek to progress to a large, global Phase 2b/3 safety and efficacy trial. That trial may involve up to 30,000 healthy participants and is anticipated to begin in late July, if regulatory approval to proceed is received. The preliminary clinical data from this ongoing study have been submitted for potential publication in a peer-reviewed journal and is available on an online preprint manuscript server. The BNT162b1 candidate remains under clinical study and is not currently approved for distribution anywhere in the world. If the ongoing studies are successful and the vaccine candidate receives regulatory approval, the companies expect to manufacture up to 100M doses by the end of 2020 and potentially more than 1.2B doses by the end of 2021. In that event, BioNTech and Pfizer would work jointly to distribute the potential COVID-19 vaccine worldwide.

ShowHide Related Items >><<
PFE Pfizer
$32.69 /

+0.04 (+0.12%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

06/30/20 H.C. Wainwright
BioNTech downgraded to Neutral from Buy at H.C. Wainwright
06/29/20 Mizuho
Pfizer resumed with a Buy at Mizuho
06/25/20 Piper Sandler
Aptevo Therapeutics price target raised to $24 from $18.50 at Piper Sandler
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

06/25/20 H.C. Wainwright
BioNTech price target lowered to $63 from $69 at H.C. Wainwright
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
04/28/20 BofA
BioNTech downgraded to Neutral from Buy at BofA
PFE Pfizer
$32.69 /

+0.04 (+0.12%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$32.69 /

+0.04 (+0.12%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

PFE Pfizer
$32.69 /

+0.04 (+0.12%)

BNTX BioNTech
$66.74 /

+1.025 (+1.56%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.